Pharmaceutical glass is classified according to its hydrolytic resistance (its ability to resist corrosion when in contact with water under certain circumstances), which is influenced by the chemical composition of the glass and by any surface treatments. The following types are listed from lowest to highest hydrolytic resistance.
Type III glass is soda-lime silicate glass, which contains little or no boron.
Type II glass is treated soda-lime silicate glass, which begins as Type III glass and undergoes a surface treatment to increase its hydrolytic resistance.
Type I glass has the highest hydrolytic resistance. Under the updated USP <660>, the following compositions can qualify as Type I:
- Borosilicate glass contains boron and silicon, along with smaller quantities of other components like aluminum oxide. Varying the proportions of these components leads to borosilicate glass with different thermal expansion properties, such as 33 expansion, 51 expansion, and 70 expansion borosilicates.
- Aluminosilicate glass is similar to borosilicate glass but with no boron and a relatively high proportion of aluminum oxide.
- Fused quartz is made of nearly pure SiO2 (silicon dioxide).
Type I glass is considered generally suitable for packaging parenteral products, while Types II and III are less suitable for this purpose due to their potential to negatively impact drug safety, efficacy, and quality. The preference to use Type I glass for parenteral drugs is primarily due to chemical resistance, although Types II and III glass still have common uses in the pharmaceutical industry for oral drugs such as solid tablets, liquid suspensions, and syrups. However, the use of Type I glass does not automatically guarantee compatibility with a given drug product. Additional drug stability studies must be conducted to verify compatibility.